Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, IMPLAD Partner to Sequence Medicinal Plants

NEW YORK (GenomeWeb) – Illumina announced yesterday that it has partnered with China's Institute of Medicinal Plant Development (IMPLAD) to create a genomic reference catalog for medicinal plants used in traditional Chinese medicine (TCM).

Under the terms of the collaboration, Illumina will perform next-generation sequencing on DNA samples from roughly 500 medicinal plants identified by IMPLAD. The institute will then assemble and annotate the chloroplast genomes with help from Illumina. Pending a review of this work, the two may negotiate a second agreement to sequence an additional 500 medicinal plants to complete IMPLAD's One Thousand Medicinal Plant Genome initiative.

Additional terms were not disclosed.

"With the rapid development of TCM markets around the world, a genomic reference for the plant species used in Chinese medicine would ensure the quality, safety, and effectiveness of TCM products," Shilin Chen, director of the Institute of Materia Medica and IMPLAD advisor, said in a statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.